EN DE
STOCK COMPARISON

Johnson & Johnson vs UnitedHealth Group: Fair Value & Quality

Both stocks run through our valuation models. Here is how Johnson & Johnson (JNJ) and UnitedHealth Group (UNH) compare, as of Aug 14, 2026.

As of Aug 14, 2026, Fair Value Calculator sees UnitedHealth Group as the more attractively valued of the two: Johnson & Johnson trades at $262 versus a fair value of $169 (-36%), while UnitedHealth Group trades at $399 versus $526 (+32%).
Johnson & Johnson
JNJ · USD · Health Care
-36%
upside to fair value
overvalued
Price$262
Fair Value$169
Quality81/100
UnitedHealth Group
UNH · USD · Health Care
+32%
upside to fair value
undervalued
Price$399
Fair Value$526
Quality62/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Johnson & JohnsonUnitedHealth Group
Valuation
29.4×P/E (TTM)31.9×
6.34×P/S (TTM)0.86×
7.49×P/B4.09×
18.4×EV/EBITDA20.2×
4.95×PEG1.49×
2.0%Dividend yield2.1%
$5.20Dividend per share$8.84
Profitability
22%Net margin3%
27%Operating margin8%
26%Return on equity12%
8%Return on assets4%
Growth
10%Revenue growth (YoY)2%
5.6%Avg. growth/yr (3Y)11.4%
2.7%Avg. growth/yr (5Y)11.7%
Balance & size
0.48×Debt / equity0.77×
$611BMarket cap$384B
healthyGrowth qualityhealthy

Johnson & Johnson leads: 8 to 6 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Johnson & Johnsonof which business quality 76 · market factors 84 UnitedHealth Groupof which business quality 60 · market factors 79
ProfitabilityMargins and returns on capital today
74
52
Quality GrowthAre margins and returns improving?
73
48
CashflowEarnings quality: real cash, not paper profit
70
52
Fin. StrengthBalance sheet, leverage, solvency risk
72
51
InvestmentDisciplined investing over empire-building
87
76
Low VolatilityCalm price path (market factor)
96
69
MomentumPrice trend over the last 3–12 months (market factor)
69
81
52W MomentumDistance to the 52-week high (market factor)
94
85
Net IssuanceBuybacks instead of dilution
90
99

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Johnson & Johnson

DCF Models$171
Earnings-Based$73.34
Dividend Discount$93.41
Multiples$163
Asset-Based$22.70
Growth DCF$129
Economic Profit$102
Growth Earnings$207

26 of 26 models see the stock below the current price.

UnitedHealth Group

DCF Models$362
Earnings-Based$196
Multiples$259
Asset-Based$69.43
Growth DCF$382
Economic Profit$186
Growth Earnings$292

19 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Johnson & Johnson
Bear $106Fair Value $169Bull $255
$262 = current price (white tick)
UnitedHealth Group
Bear $368Fair Value $526Bull $657
$399 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Johnson & Johnson · Health Care

Quality score81 · Top 25%
Fair value upside-36% · below median

UnitedHealth Group · Health Care

Quality score62 · above median
Fair value upside+32% · Top 25%

Bottom line

As of Aug 14, 2026, Fair Value Calculator sees UnitedHealth Group as the more attractively valued of the two: Johnson & Johnson trades at $262 versus a fair value of $169 (-36%), while UnitedHealth Group trades at $399 versus $526 (+32%).

Johnson & Johnson has the higher quality score (81/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.